Emergent Biosolutions
EBS
EBS
276 hedge funds and large institutions have $2.22B invested in Emergent Biosolutions in 2021 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 110 increasing their positions, 96 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
276
Holders Change
-14
Holders Change %
-4.83%
% of All Funds
4.85%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
22
Increased
110
Reduced
96
Closed
33
Calls
$5.88M
Puts
$5.79M
Net Calls
+$91K
Net Calls Change
+$4.44M
Top Buyers
Top Sellers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
$144M |
| 2 |
Two Sigma Investments
New York
|
$0 |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
$18.2M |
| 4 |
Two Sigma Advisers
New York
|
$270K |
| 5 |
Morgan Stanley
New York
|
$14.8M |
